DIA/FDA Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

会议日程

天 1 2017 年 10 月 25 日

11:00 AM — 12:30 PM

Session 2A: Control Strategy for Double-Stranded Oligonucleotides

1:30 PM — 3:00 PM

Session 3A: Starting Materials: Beyond Simple DNA and RNA Derived Phosphoramidites

天 2 2017 年 10 月 26 日

10:30 AM — 12:00 PM

Session 6A: Thinking Ahead: Oligonucleotide Drug-Device Combination Products

1:30 PM — 3:00 PM

Session 7A: Recently Approved and Late-Stage Oligonucleotide Drugs

天 3 2017 年 10 月 27 日

8:00 AM — 9:30 AM

Session 9A: Interactive Discussion of CMC Challenges and Moving Forward